arginine and Thromboembolism

arginine has been researched along with Thromboembolism in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.56)18.7374
1990's10 (27.78)18.2507
2000's14 (38.89)29.6817
2010's9 (25.00)24.3611
2020's1 (2.78)2.80

Authors

AuthorsStudies
Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ1
Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J1
Al-Eidan, FAS; Alrawkan, S; Alshammary, H; Crowther, MA1
Pötzsch, B1
Hirade, R; Mihara, T; Nikai, T; Ota, J; Saito, Y; Sakakibara, S1
Ansell, J; Bakhru, S; Costin, J; Laulicht, B; Steiner, S1
Baumgarten, G; Boehm, O; Graeff, I; Hoeft, A; Kim, SC; Schewe, JC; Tran, N; Wittmann, M1
Kaatz, S; Milling, TJ1
Boggio, LN; Oza, VM1
Haeberle, L; Nohe, B; Ploppa, A; Schmid, E1
Hetzer, R; Koster, A; Krabatsch, T; Maj, G; Pappalardo, F; Potapov, E; Scandroglio, AM; Stepanenko, A; Zangrillo, A1
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K1
Damiano, RJ; Deshpande, SP; Lawton, JS; Zanaboni, PB1
Bhatt, DL; Gurm, HS1
Büller, HR; Di Nisio, M; Middeldorp, S1
Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D1
Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM1
Bonderman, D; Hitsch, R; Jakowitsch, J; Klepetko, W; Kneussl, MP; Lang, IM; Mittermayer, F; Panzenboeck, A; Sadushi, R; Skoro-Sajer, N; Wolzt, M1
Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F1
Berends, F; Büller, H; Koopman, R; Mertens, K; Roelse, J; ten Cate, JW; van Mourik, JA; Voorberg, J1
Ameriso, SF; Fernandez, JA; Fisher, M; Griffin, JH; Gruber, A; Paganini-Hill, A; Xie, D1
Alving, BM; Carrington, LR; Gillespie, DL; Griffin, JH1
Dübbers, A; Nowak-Göttl, U; Oleszuk-Raschke, K; Sträter, R; Vielhaber, H1
Johnsen, AH; Lind, B; Thorsen, S1
Busto, R; Dietrich, WD; Green, EJ; Prado, R; Stagliano, NE1
Dewanjee, MK1
Broeders, MA; oude Egbrink, MG; Reneman, RS; Slaaf, DW; Tangelder, GJ2
Barrowcliffe, TW; Goodnight, SH; Green, D; Laposata, M; Sosolik, RC; Van Cott, EM1
Hoson, M; Kawada, T; Kitagawa, H; Okada, Y; Shiomura, J1
Kondo, LM; Wiggins, BS; Wittkowsky, AK1
Fleischer, K; Gulba, DC; Lankes, W1
Rezaei Kalantari, H1
Cooper, DN; Grundy, CB; Kakkar, VV; Kobosko, J; Krawczak, M; Schulman, S1
Beresford, CH; Carrell, RW; Owen, MC1
Kirsteins, L; Lawrence, AM1

Reviews

11 review(s) available for arginine and Thromboembolism

ArticleYear
[Anticoagulation].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:4

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K

2013
Reversal agents in development for the new oral anticoagulants.
    Postgraduate medicine, 2014, Volume: 126, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Piperazines; Recombinant Proteins; Thromboembolism

2014
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
    The American journal of medicine, 2016, Volume: 129, Issue:11S

    Topics: Animals; Antidotes; Arginine; Atrial Fibrillation; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thromboembolism

2016
Argatroban use in heparin-induced thrombocytopenia.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:11

    Topics: Anticoagulants; Arginine; Clinical Trials as Topic; Heparin; Humans; Liver; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism

2008
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
    American heart journal, 2005, Volume: 149, Issue:1 Suppl

    Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis

2005
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:6

    Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome

2006
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
    Archives of pathology & laboratory medicine, 1998, Volume: 122, Issue:9

    Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pathology, Clinical; Pipecolic Acids; Sulfonamides; Thromboembolism

1998
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation.
    Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:2

    Topics: Animals; Anticoagulants; Arginine; Child; Extracorporeal Circulation; Heart Bypass, Left; Heparin; Humans; Pediatrics; Pipecolic Acids; Sulfonamides; Thromboembolism

2000
Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:4

    Topics: Animals; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism

2001
[Direct thrombin antagonists].
    Herz, 2001, Volume: 26 Suppl 1

    Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombins; Arginine; Azetidines; Benzylamines; Fibrinolytic Agents; Glycine; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Time Factors

2001
[How I treat ... sickle cell anemia: current therapies].
    Revue medicale de Liege, 2001, Volume: 56, Issue:10

    Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antisickling Agents; Arginine; Aspirin; Blood Transfusion; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Hydroxyurea; Nitric Oxide; Thromboembolism; Transplantation, Homologous

2001

Other Studies

25 other study(ies) available for arginine and Thromboembolism

ArticleYear
Development of a carotid artery thrombolysis stroke model in mice.
    Blood advances, 2022, 09-27, Volume: 6, Issue:18

    Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2022
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Journal of the American College of Cardiology, 2017, Nov-28, Volume: 70, Issue:21

    Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome

2017
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
    Annals of hematology, 2018, Volume: 97, Issue:11

    Topics: Aged; Arginine; Fondaparinux; Heparin; Humans; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism

2018
[Recipient of living kidney transplantation during which heparin-induced thrombocytopenia (HIT) was suspected: a case report].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:3

    Topics: Aged; Anesthesia, General; Anticoagulants; Antithrombins; Arginine; Diabetic Nephropathies; Drug Substitution; Female; Heparin; Humans; Kidney Transplantation; Living Donors; Perioperative Care; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome

2014
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
    Journal of cardiothoracic surgery, 2015, Feb-07, Volume: 10

    Topics: Adult; Aged; Anticoagulants; Arginine; Critical Illness; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Health Care Costs; Hemorrhage; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism

2015
Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
    Journal of cardiothoracic and vascular anesthesia, 2013, Volume: 27, Issue:4

    Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Thromboembolism; Ventricular Dysfunction, Left

2013
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Minerva anestesiologica, 2012, Volume: 78, Issue:3

    Topics: Adult; Aged; Anticoagulants; Arginine; Feasibility Studies; Female; Heart Transplantation; Heart-Assist Devices; Heparin; Hospital Mortality; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome

2012
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
    Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:1

    Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography

2003
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting.
    The Annals of thoracic surgery, 2005, Volume: 79, Issue:1

    Topics: Aged; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Emergencies; Fatal Outcome; Female; Heart Injuries; Heparin; Humans; Hypertension, Pulmonary; Internal Mammary-Coronary Artery Anastomosis; Intraoperative Complications; Mitral Valve; Myocardial Infarction; Pipecolic Acids; Postoperative Complications; Rupture, Spontaneous; Sulfonamides; Suture Techniques; Thrombocytopenia; Thromboembolism

2005
Direct thrombin inhibitors.
    The New England journal of medicine, 2005, Sep-08, Volume: 353, Issue:10

    Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis

2005
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Journal of internal medicine, 2005, Volume: 258, Issue:6

    Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin

2005
Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    American journal of respiratory and critical care medicine, 2007, Dec-01, Volume: 176, Issue:11

    Topics: Aged; Arginine; Chronic Disease; Endothelial Cells; Enzyme Inhibitors; Female; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Male; Middle Aged; Nitric Oxide Synthase; Osmolar Concentration; Prognosis; Pulmonary Artery; Severity of Illness Index; Thromboembolism

2007
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2007, Volume: 13, Issue:5

    Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism

2007
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Lancet (London, England), 1994, Jun-18, Volume: 343, Issue:8912

    Topics: Adult; Aged; Arginine; Base Composition; Base Sequence; DNA Primers; Factor V; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Point Mutation; Protein C; Recurrence; Thromboembolism

1994
Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.
    Stroke, 1996, Volume: 27, Issue:7

    Topics: Arginine; Blood Coagulation; Brain Ischemia; Carrier Proteins; Cerebrovascular Disorders; Factor V; Female; Glutamine; Hispanic or Latino; Humans; Los Angeles; Male; Middle Aged; Partial Thromboplastin Time; Point Mutation; Prevalence; Risk Factors; Thromboembolism

1996
Resistance to activated protein C: a common inherited cause of venous thrombosis.
    Annals of vascular surgery, 1996, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Arginine; Contraceptives, Oral; DNA; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity; Pregnancy; Protein C; Protein C Deficiency; Protein S Deficiency; Recurrence; Risk Factors; Thromboembolism; Thrombophlebitis

1996
Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:7

    Topics: Adolescent; Arginine; Arterial Occlusive Diseases; Brain Ischemia; Child; Child, Preschool; Enzyme Activation; Factor V; Female; Glutamine; Humans; Infant; Infant, Newborn; Male; Point Mutation; Prospective Studies; Protein C; Risk Factors; Thromboembolism

1996
Naturally occurring Arg(-1) to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C.
    Blood, 1997, Apr-15, Volume: 89, Issue:8

    Topics: Amino Acid Sequence; Antimicrobial Cationic Peptides; Arginine; Disease Susceptibility; Histidine; Humans; Male; Middle Aged; Peptides; Point Mutation; Protein C; Protein C Deficiency; Protein Precursors; Protein Processing, Post-Translational; Thromboembolism

1997
The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat.
    Brain research, 1997, Jun-06, Volume: 759, Issue:1

    Topics: Animals; Arginine; Behavior, Animal; Blood Pressure; Cerebrovascular Disorders; Citrulline; Cognition Disorders; Enzyme Inhibitors; Intracranial Embolism and Thrombosis; Male; Motor Cortex; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Somatosensory Cortex; Thromboembolism

1997
Stroke from heparin-coated circuits and reduced systemic anticoagulation.
    The Annals of thoracic surgery, 1997, Volume: 64, Issue:4

    Topics: Animals; Anticoagulants; Arginine; Cardiopulmonary Bypass; Cerebrovascular Disorders; Heparin; Humans; Male; Swine; Thromboembolism

1997
Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles.
    Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:1

    Topics: Animals; Arginine; Arterioles; Female; Male; Microscopy, Video; Nitric Oxide; Nitroarginine; Nitroprusside; Rabbits; Rupture; Thromboembolism; Venules

1998
Hypercholesterolemia enhances thromboembolism in arterioles but not venules: complete reversal by L-arginine.
    Arteriosclerosis, thrombosis, and vascular biology, 2002, Apr-01, Volume: 22, Issue:4

    Topics: Animals; Arginine; Arterioles; Diet, Atherogenic; Hypercholesterolemia; Male; Nitric Oxide; Rabbits; Thromboembolism; Time Factors; Venules

2002
Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene.
    Human genetics, 1992, Volume: 88, Issue:5

    Topics: Amino Acid Sequence; Arginine; Base Sequence; Exons; Female; Genetic Carrier Screening; Humans; Male; Molecular Sequence Data; Mutation; Oligodeoxyribonucleotides; Pedigree; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein C; Protein C Deficiency; Thromboembolism

1992
Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    FEBS letters, 1988, Apr-25, Volume: 231, Issue:2

    Topics: Adult; Amino Acid Sequence; Antithrombin III; Arginine; Binding Sites; Heparin; Histidine; Humans; Male; Thrombin; Thromboembolism

1988
Progestins in the medical management of active acromegaly.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:5

    Topics: Acromegaly; Arginine; Carcinoma; Depression, Chemical; Endometrial Hyperplasia; Estrogens; Female; Feminization; Glucose Tolerance Test; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Immunoassay; Medroxyprogesterone; Metrorrhagia; Thromboembolism

1970